the efficacy data do not clearly show that PTH should be selected over antiresorptive therapies for the treatment of osteoporosis. In addition, PTH is expensive and must be administered daily via ...

It is World Osteoporosis Day this month, and Ben Hargreaves takes a look at what treatment options look like for patients living with the disease. Osteoporosis is a condition that causes bones to ...

The Bon Secours’ Health Matters segment for this month focuses on Osteoporosis. It’s a condition that causes a person’s bones ...

Treatment-dependent relative risks (or therapy ... identified in the Lips [25] review of studies of quality of life in osteoporosis. The model used a 57% relative risk reduction (RR = 0.43 ...

500 healthcare professionals, 11 chairpersons, and 15 distinguished speakers for in-depth discussions on advancements in ...

Non-communicable diseases, including cancers such as lung, liver, and breast cancer, account for 77% of total deaths in ...

Osteoporosis is one of the common bone diseases resulted due to loss in bone mass. This disease starts developing when the body consumes more bone tissue than it produces; thus, this reduces the bone ...

Two Key Genes Identified Linking Rheumatoid Arthritis and Osteoporosis Nov ... serve as diagnostic tools and potential targets for treatments. Drawing from a large database of ...

In Finland, hormonal treatments can be given to adolescents if it is clear that their identity ... but encourages “the greatest reserve” in their use given the potential long-term side effects, which ...

The Philippine Orthopaedic Association (POA) marked a milestone with its 75th Annual Congress held from Nov. 13 to 16, 2024 ...

Lucknow University's science department has filed for six innovative patents, including a groundbreaking osteoporosis ...

Fintel reports that on December 12, 2024, BTIG downgraded their outlook for Keros Therapeutics (NasdaqGM:KROS) from Buy to ...